Hong-Wu Shen

发表

Modification of 5-methoxy-N, N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2016, Pharmacological reports : PR.

Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice

D. Mager, A. Yu, S. Schmidt, 2016, Acta pharmaceutica Sinica. B.

Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2015, Neuropharmacology.

Altered Expression of Small Heterodimer Partner Governs Cytochrome P450 (CYP) 2D6 Induction during Pregnancy in CYP2D6-humanized Mice*

F. Gonzalez, Hyunyoung Jeong, A. Yu, 2013, The Journal of Biological Chemistry.

Difference in desipramine metabolic profile between wild-type and CYP2D6-humanized mice.

A. Yu, Hong-Wu Shen, 2009, Drug metabolism letters.

New analytical technologies for biological discovery

A. Yu, Hong-Wu Shen, 2010 .

Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N , N-Dimethyltryptamine , and the Impact of CYP 2 D 6 Status

D. Mager, A. Yu, Xi-ling Jiang, 2013 .

Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status

D. Mager, A. Yu, Xi-ling Jiang, 2013, Drug Metabolism and Disposition.

Pinoline May be Used as a Probe for CYP2D6 Activity

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2009, Drug Metabolism and Disposition.

Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2009, Biochemical pharmacology.

Pinoline May Be Utilized as a Probe for CYP 2 D 6 Activity

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2008 .

Microsoft Word-23255875-file00

Xi-ling Jiang, Hong-Wu Shen, Ai‐Ming Yu, 2011 .

Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study.

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2009, Bioanalysis.

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

J. C. Winter, A. Yu, Xi-ling Jiang, 2010, Current drug metabolism.

The Riboswitch Regulates a Thiamine Pyrophosphate ABC Transporter of the Oral Spirochete Treponema denticola

Aiming Yu, Chunhao Li, Jiang Bian, 2011, Journal of bacteriology.

Humanized transgenic mouse models for drug metabolism and pharmacokinetic research.

F. Gonzalez, A. Yu, Xi-ling Jiang, 2011, Current drug metabolism.

Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2010, Biochemical pharmacology.

Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice

Hong-Wu Shen, Ai-Ming Yu, A. Yu, 2011, Drug Metabolism and Disposition.

Conference report: new analytical technologies for biological discovery.

Hong-Wu Shen, Ai-Ming Yu, A. Yu, 2010, Bioanalysis.

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

J. C. Winter, A. Yu, Xi-ling Jiang, 2010, Current drug metabolism.